Dual-Action Combination Therapy Enhances Angiogenesis while Reducing Tumor Growth and Spread by Wong, Ping-Pui, Demircioglu, Fevzi, Ghazaly, Essam, Alrawashdeh, Wasfi, Stratford, Michael R.L., Scudamore, Cheryl L., Cereser, Biancastella, Crnogorac-Jurcevic, Tatjana, McDonald, Stuart, Elia, George, Hagemann, Thorsten, Kocher, Hemant M., Hodivala-Dilke, Kairbaan M.

Get full text

The influence of catechol structure on the suicide-inactivation of tyrosinase by Ramsden, Christopher A, Stratford, Michael R L, Riley, Patrick A

Get full text

Radiosensitization In Vivo by Histone Deacetylase Inhibition with No Increase in Early Normal Tissue Radiation Toxicity by Groselj, Blaz, Ruan, Jia-Ling, Scott, Helen, Gorrill, Jessica, Nicholson, Judith, Kelly, Jacqueline, Anbalagan, Selvakumar, Thompson, James, Stratford, Michael R L, Jevons, Sarah J, Hammond, Ester M, Scudamore, Cheryl L, Kerr, Martin, Kiltie, Anne E

Get full text

Phase I Clinical and Pharmacokinetic Evaluation of the Vascular-Disrupting Agent OXi4503 in Patients with Advanced Solid Tumors by PATTERSON, Dan M, ZWEIFEL, Martin, CHAPLIN, Dai J, PADHANI, Anwar R, RUSTIN, Gordon J. S, MIDDLETON, Mark R, PRICE, Patricia M, FOLKES, Lisa K, STRATFORD, Michael R. L, ROSS, Phil, HALFORD, Sarah, PETERS, Jane, BALKISSOON, Jai

Get full text

Validation of a method for the determination of the anticancer agent Combretastatin A1 phosphate (CA1P, OXi4503) in human plasma by HPLC with post-column photolysis and fluorescenc... by Stratford, Michael R.L., Folkes, Lisa K.

Get full text

Mechanistic studies of the inactivation of tyrosinase by resorcinol by Stratford, Michael R.L., Ramsden, Christopher A., Riley, Patrick A.

Get full text

Deoxycytidine kinase expression underpins response to gemcitabine in bladder cancer by Kerr, Martin, Scott, Helen E, Groselj, Blaz, Stratford, Michael R L, Karaszi, Katalin, Sharma, Naomi L, Kiltie, Anne E

Get full text

The influence of hydroquinone on tyrosinase kinetics by Stratford, Michael R.L., Ramsden, Christopher A., Riley, Patrick A.

Get full text

Oxidative Metabolism of Combretastatin A-1 Produces Quinone Intermediates with the Potential To Bind to Nucleophiles and To Enhance Oxidative Stress via Free Radicals by Folkes, Lisa K, Christlieb, Martin, Madej, Edyta, Stratford, Michael R. L, Wardman, Peter

Get full text

Enhanced fluorescence detection of cis-combretastatins by post-column photolysis by Stratford, Michael R.L.

Get full text

A validated HPLC method with fluorescence detection for the glucuronides of Combretastatin A1 in human plasma, and studies on their cis–trans isomerisation by Stratford, Michael R.L., Folkes, Lisa K.

Get full text

Hypoxia-driven elimination of thiopurines from their nitrobenzyl prodrugs by Thomson, Peter, Naylor, Matthew A., Stratford, Michael R.L., Lewis, Gemma, Hill, Sally, Patel, Kantilal B., Wardman, Peter, Davis, Peter D.

Get full text

Rapid Halogen Substitution and Dibenzodioxin Formation during Tyrosinase-Catalyzed Oxidation of 4-Halocatechols by Stratford, Michael R. L, Riley, Patrick A, Ramsden, Christopher A

Get full text

Quantitative determination of the anticancer prodrug combretastatin A1 phosphate (OXi4503, CA1P), the active CA1 and its glucuronide metabolites in human urine and of CA1 in plasma... by Stratford, Michael R.L., Folkes, Lisa K.

Get full text

A phase 1 study to assess the safety, tolerability, and pharmacokinetics of CXD101 in patients with advanced cancer by Eyre, Toby A., Collins, Graham P., Gupta, Avinash, Coupe, Nicholas, Sheikh, Semira, Whittaker, John, Wang, Lai Mun, Campo, Leticia, Soilleux, Elizabeth, Tysoe, Finn, Cousins, Richard, La Thangue, Nick, Folkes, Lisa K., Stratford, Michael R. L., Kerr, David, Middleton, Mark R.

Get full text

A first-in-human phase I study to determine the maximum tolerated dose of the oral Src/ABL inhibitor AZD0424 by Woodcock, Victoria K, Clive, Sally, Wilson, Richard H, Coyle, Vicky M, Stratford, Michael R L, Folkes, Lisa K, Eastell, Richard, Barton, Claire, Jones, Paul, Kazmi-Stokes, Shamim, Turner, Helen, Halford, Sarah, Harris, Adrian L, Middleton, Mark R

Get full text

Synthesis and biological properties of bioreductively targeted nitrothienyl prodrugs of combretastatin A-4 by Thomson, Peter, Naylor, Matthew A, Everett, Steven A, Stratford, Michael R L, Lewis, Gemma, Hill, Sally, Patel, Kantilal B, Wardman, Peter, Davis, Peter D

Get full text

Oxidative calcium release from catechol by Riley, Patrick A., Stratford, Michael R.L.

Get full text

ZD6126: A novel vascular-targeting agent that causes selective destruction of tumor vasculature by DAVIS, Peter D, DOUGHERTY, Graeme J, HILL, Sally A, BLAKEY, David C, GALBRAITH, Susan M, TOZER, Gillian M, HOLDER, Angela L, NAYLOR, Matthew A, NOLAN, John, STRATFORD, Michael R. L, CHAPLIN, David J

Get full text

Investigation of the anomalous action of 5-hydroxyresorcinol on tyrosinase by Land, Edward J., Ramsden, Christopher A., Riley, Patrick A., Stratford, Michael R. L.

Get full text